Edwards Lifesciences Corporation (EW) : Tuesdays money flow points at investors jumping to buy the stock on the weakness of price. $31.21 million worth of transactions were on upticks, whereas, the downticks accounted for $25.44 million worth of transactions. The net money flow was a positive $5.77 million and the uptick to downtick ratio was 1.23. However, the block trades showed a clear dominance of the bulls with a very healthy ratio of 3.28 in their favor. The net money flow into the stock was $5.36 million. The value of block trades done on downticks was only $2.35 million. The lack of interest in trading on downticks shows that the investors dont want to sell their holdings. The upticks accounted for $7.71 million of the total block trades, indicating continued buying interest on weakness, which bodes well for the future of the stock. Edwards Lifesciences Corporation (EW) was trading at $104.48, down $0.24 during day. The stock slid -0.23% over the previous days close. For the week, the stock recorded 5.98% over the previous weeks close.
The company Insiders own 2.37% of Edwards Lifesciences Corporation shares according to the proxy statements. Institutional Investors own 87.16% of Edwards Lifesciences Corporation shares. In an insider trading activity, The officer (CVP, Japan & Intercontinental), of Edwards Lifesciences Corp, Wang Huimin had unloaded 13,650 shares at $98.44 per share in a transaction on July 5, 2016. The total value of transaction was $1,343,706. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Shares of Edwards Lifesciences Corp. rose by 6.66% in the last five trading days and 4.68% for the last 4 weeks. Edwards Lifesciences Corp. is up 0.5% in the last 3-month period. Year-to-Date the stock performance stands at 34.55%.
Edwards Lifesciences Corporation (NYSE:EW): stock turned positive on Tuesday. Though the stock opened at $104.95, the bulls momentum made the stock top out at $106.555 level for the day. The stock recorded a low of $104.62 and closed the trading day at $106.27, in the green by 1.71%. The total traded volume for the day was 1,912,498. The stock had closed at $104.48 in the previous days trading.
Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. It is a manufacturer of heart valve systems and repair products used to replace or repair a patients diseased or defective heart valve. The Company develops hemodynamic monitoring systems used to measure a patients cardiovascular function in the hospital setting. Patients in the hospital setting, including high-risk patients in the operating room or intensive care unit, are candidates for having their cardiac function or fluid levels monitored by the its Critical Care products. The Companys products and technologies it offers to treat advanced cardiovascular disease are categorized into three main areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care.